Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease (Q44626972)

4 December 2017

Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease (English)

1 reference

4 December 2017

0 references

1

1 reference

4 December 2017

5

1 reference

4 December 2017

6

1 reference

4 December 2017

W D Hirst

2

1 reference

4 December 2017

C P L-H Chen

series ordinal

3

1 reference

4 December 2017

B Lasheras

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

4 December 2017

Neuropsychopharmacology

1 reference

4 December 2017

29

1 reference

4 December 2017

2

1 reference

4 December 2017

410-416

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300330

4 December 2017

0 references

cites work

Gene expression profiling in the post-mortem human brain--no cause for dismay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The serotonin hypothesis of aggression revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

5-ht6 receptors as emerging targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Serotonin receptors in cognitive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Role of serotonin in memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Serotonin in Alzheimer-type dementia and other dementing illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Evidence that 5-hydroxytryptamine release in rat dorsal raphé nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The basis for behavioural disturbances in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

A rapid radiochemical method for the determination of choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Behaviour changes in dementia. 1: Point of entry data of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The medical benefit of 5-HT research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Natural history of aggressive behaviour in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The frequency and troublesomeness of symptoms associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Could the 5-HT1B receptor inverse agonism affect learning consolidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Effects of the 5-HT receptor antagonists GR127935 (5-HT1B/1D) and MDL100907 (5-HT2A) in the consolidation of learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Pharmacological treatment of non-cognitive disturbances in dementia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Convergent cholinergic activities in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Presynaptic regulation of acetylcholine release in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

5-HT6 receptor antagonists enhance retention of a water maze task in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Differential sensitivity of 5-HT1B auto and heteroreceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Cognitive functions of cortical acetylcholine: toward a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300330

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300330

1 reference

4 December 2017

1 reference